{
  "created_at": "Wed Apr 07 23:44:54 +0000 2021",
  "id_str": "1379919632925134851",
  "full_text": "Both Britain’s health officials and the European Medicines Agency have said there is strong evidence that AstraZeneca’s covid-19 vaccine may be linked with very rare blood clots https://t.co/WuZDAs7fPz",
  "display_text_range": [
    0,
    201
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/WuZDAs7fPz",
        "expanded_url": "https://econ.st/31UZ8mK",
        "display_url": "econ.st/31UZ8mK",
        "indices": [
          178,
          201
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 39,
  "favorite_count": 78,
  "possibly_sensitive": false,
  "original_created_at": "Wed Apr 07 22:10:52 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "英国の保健当局と欧州医薬品庁は、アストラゼネカ社のコビド19ワクチンが非常に稀な血栓と関連している可能性があるという強い証拠があると発表した https://t.co/WuZDAs7fPz"
    },
    {
      "locale": "zh",
      "full_text": "英国卫生官员和欧洲药品管理局都表示，有强有力的证据表明，阿斯利康公司的covid-19疫苗可能与非常罕见的血栓有关https://t.co/WuZDAs7fPz。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "英國衛生官員和歐洲藥品管理局都表示，有強有力的證據表明，阿斯利康公司的covid-19疫苗可能與非常罕見的血栓有關https://t.co/WuZDAs7fPz。"
    }
  ]
}